Using the BLA-BLIP enzyme switch sensor with anti-idiotypic (anti-ID) Affimer proteins, we previously detected trastuzumab (Herceptin), a TmAb used in the treatment of HER2+ breast carcinoma (Goldenberg, 1999). This evidence concerns the gene ERBB2 and breast carcinoma.